Device Trial Radar · NCT04025762
24/7 Closed-loop in Older Subjects With Type 1 Diabetes
Last checked: Nov 19, 2026Latest source record: Dec 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
38
Actual
Start
Sep 1, 2019
Primary completion
Aug 20, 2021
Study completion Aug 20, 2021
Sponsor
- Lead sponsor
- University of CambridgeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Manchester University NHS Foundation Trust; University Hospital Birmingham NHS Foundation Trust; Medical University of Graz
- First posted
- Jul 19, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of this open-label, multi-centre, randomised, crossover design study is to determine whether automated day and night closed-loop insulin delivery for 16 weeks under free living conditions is safer and more efficacious compared to sensor augmented insulin pump therapy in older adults with type 1 diabetes. The primary outcome is time spent in target range between 3.9 and 10.0 mmol/L (70 and 180 mg/dl) as recorded by CGM. Secondary outcomes are the HbA1c, time spent with glucose levels above and below target, as recorded by CGM, and other CGM-based metrics. Measures of human factor assessments, cardiac arrhythmias and objective sleep quality assessment will also be evaluated in this study.
Conditions
- Type 1 Diabetes Mellitus
- Hypoglycemia
- Arrythmia
Interventions
Hybrid closed-loop system (CamAPS FX)Device
Hybrid closed-loop system
Sensor augmented pump therapyDevice
Sensor augmented pump therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Time Spent in the Target Sensor Glucose Range During the 16 Week Intervention Period (%)Time frame: 16 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
Manchester Royal Infirmary
Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.